Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

NOVARTIS INDIA LTD.

NSE : NOVARTINDBSE : 500672ISIN CODE : INE234A01025Industry : TradingHouse : Novartis India - MNC

BSE875.9513 (+1.51 %)

PREV CLOSE ( ) 862.95

OPEN PRICE ( ) 873.85

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2690

TODAY'S LOW / HIGH ( )865.00 884.75

52 WK LOW / HIGH ( )744.95 1115

NSE672.250 (0 %)

PREV CLOSE( ) 672.25

OPEN PRICE ( ) 691.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 672.25 (249)

VOLUME 11837

TODAY'S LOW / HIGH( ) 668.35 698.20

52 WK LOW / HIGH ( )668.35 698.2

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-12 1947

Management Info

Christopher Snook - Chairman - Managing Director

Registered Office

Address The Inspire B K C, 7th Floor,Bandra Kurla Complex,Bandra (East),
Mumbai,
Maharashtra-400051

Phone 022-50243000

Email india.investors@novartis.com

Website www.novartis.in

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

10May Novartis India informs about appointm
Pursuant to Regulation 24(A) and Regulation 30 read with Para A of Part..

10May Novartis India informs about reappoint
Novartis India has informed that the Board has approved the Re-appointme..

10May Novartis India informs about newspaper
Pursuant to Regulation 4 7 of the Securities and Exchange Board of India..

04Jul Novartis India informs about loss of s
Novartis India has informed that it enclosed intimation under regulation..

15May Novartis India informs about loss of s
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclo..

Financials

Rs. in Millions

	QTR Jun 25	ANNUAL 25
Net Profit	276.2	1009
Gross Profit	372.2	1304.2
Operating Profit	378.5	1333.8
Net Sales	875.5	3562.7

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Parshva Enterprises (BSE) 324.40 (19.99%)	M.Cap ( in Cr)330.56
India Motor Parts (BSE) 1078.15 (2.55%)	M.Cap ( in Cr)1345.53
Emergent Ind Soln (BSE) 558.05 (5.00%)	M.Cap ( in Cr)254.97
SK Minerals & Add (BSE) 152.25 (19.88%)	M.Cap ( in Cr)186.35
Aptus Pharma (BSE) 129.51 (17.38%)	M.Cap ( in Cr)88.84

Shareholding Pattern

	PROMOTERS	70.68%
	NON-INSTITUTION	28.61%
	FI/BANKS/INSURANCE	0.52%
	MUTUAL FUNDS/UTI	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Bandhan BSE Healthc...	0.05
Motilal Oswal BSE H...	0.05

Risk Disclosures on Derivatives

Smart Quotes

NOVARTIS INDIA LTD.